Paper 68 - INCIDENCE AND SURVIVAL OF MALIGNANT BONE SARCOMA DIAGNOSED IN ENGLAND BETWEEN 1995 AND 2020; AN ANALYSIS FROM THE NATIONAL CANCER REGISTRATION AND ANALYSIS SERVICE

Author(s)

• 

  Reuben Hastings, MSc

  Sarcoma Analyst
  NHS England, UCL Cancer Institute
  Bristol, England, United Kingdom

  Slides

Co-Author(s)

• AB

  Andrew Bacon, MSc

  Senior Genomic Analyst
  NHS England
  Bristol, England, United Kingdom
• VV

  Victoria Vinader, PhD

  Research Manager
  Bone Cancer Research Trust
  Leeds, England, United Kingdom
• SM

  Sean McPhail, PhD

  National Disease Registration Service, NHS England
  Bristol, England, United Kingdom
• LP

  Lizz Paley, MSc (she/her/hers)

  Partnerships Analytical Lead
  NHS England
  London, England, United Kingdom
• 

  Martin G. McCabe, PhD

  Clinical senior lecturer
  University of Manchester
  Manchester, England, United Kingdom
• 

  Craig Gerrand, MD, FRCS Ed (Tr and Orth)

  Consultant Orthopaedic Surgeon
  Royal National Orthopaedic Hospital
  Stanmore, England, United Kingdom
• 

  Sandra J. Strauss, MD PhD FRCP (she/her/hers)

  Professor of Medical and TYA Oncology
  UCL Cancer Institute
  London, England, United Kingdom